Seelos Therapeutics, Inc. Long-Term Debt, Maturity, Year Three
Seelos Therapeutics, Inc. had Long-Term Debt, Maturity, Year Three of $10.19 million as of 2021-12-31, per its 10-K filed 2022-03-04.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree · last filed 2022-03-04
- 2021-12-31: Long-Term Debt, Maturity, Year Three $10.19M.
- 2015-12-31: Long-Term Debt, Maturity, Year Three $3.02M.
| Period end | Long-Term Debt, Maturity, Year Three |
|---|---|
| 2021-12-31 | $10.19M 10-K · filed 2022-03-04 |
| 2015-12-31 | $3.02M 10-K · filed 2016-03-09 |